XML 38 R31.htm IDEA: XBRL DOCUMENT v3.24.1.1.u2
Description of Business, Organization and Liquidity - Additional Information (Details)
$ / shares in Units, $ in Thousands
3 Months Ended 12 Months Ended
Feb. 12, 2024
USD ($)
$ / shares
shares
Feb. 08, 2024
Jan. 30, 2024
Mar. 31, 2024
USD ($)
shares
Mar. 31, 2023
USD ($)
Dec. 31, 2023
USD ($)
shares
Subsidiary, Sale of Stock [Line Items]            
Incorporated date       Jun. 14, 2018    
Shares issued | shares           349,321
Net proceeds       $ 341,171    
Description of reverse stock split       On January 30, 2024, the Company’s shareholders approved and the Company effected a reverse stock split of the shares of common stock at a ratio of 1-for-4.5511 (the “Reverse Stock Split”). The number of authorized shares and par value per share were not adjusted as a result of the Reverse Stock Split. All references to shares, restricted stock awards, restricted stock units and options to purchase common stock, share data, per share data, and related information contained in the financial statements have been retrospectively adjusted to reflect the effect of the Reverse Stock Split for all periods presented. The conversion ratios for each series of the Company’s redeemable convertible preferred stock, which was automatically converted into shares of common stock upon the closing of the IPO, were proportionally adjusted.    
Reverse stock split conversion ratio   0.219 0.219      
Accumulated deficit       $ 162,736   $ 136,043
Net loss       26,693 $ 11,143  
Cash and cash equivalents and available-for-sale marketable securities       $ 369,800    
Common Stock            
Subsidiary, Sale of Stock [Line Items]            
Shares issued | shares       16,675,000    
Initial Public Offering | Common Stock            
Subsidiary, Sale of Stock [Line Items]            
Shares issued | shares 16,675,000          
Share price | $ / shares $ 22          
Gross proceeds $ 366,900          
Net proceeds 336,200          
Underwriting discounts and commissions and other offering costs $ 30,700          
Underwriters option to purchase | Common Stock            
Subsidiary, Sale of Stock [Line Items]            
Shares issued | shares 2,175,000